The Center for Cancer Research and Therapeutic Development (CCRTD) was established in 1999 at Clark Atlanta University to carry-out basic research in cancer biology and drug discovery. In 2004, the CCRTD decided to concentrate in the area of prostate cancer due to disproportionately higher incidence and mortality rate of this disease in African-American men. The current proposal requests support to continue the Center of Excellence in Prostate Cancer Research, Education and Community Education. The main objectives of this center will be 1) To carry out high quality basic research in cell and molecular biology of prostate cancer and to identify underlying biological reasons for racial disparities, 2) To continue our training program for undergraduate and graduate students to provide research training in the area of prostate cancer and hence increase the number of minority (primarily African American) scientists in this area of research, 3) To expand the community-based educational program for raising awareness on prevention, screening, early detection and treatment of prostate cancer. These goals will be achieved in collaboration with the Clark Atlanta University Division of Communication Arts, Midtown Urology Educational Foundation, Saint Joseph's Hospital Men's Health and Wellness Center, and other community organizations. In the Research Core, we propose three research projects focusing on prostate cancer cell and molecular biology and racial disparities. In the Training Core, we are requesting support for training of four graduate and six undergraduate students in the area of cancer biology and community service. In the Community Outreach/Education Core, we are requesting support to expand upon the community outreach and educational activities to include a larger media arena and coverage. The overall activities of the center will be monitored by the Administrative Core. The activities of the Administrative Core will be overseen by the Institutional (lAC), External (EAC) and Local External (LEAC) Advisory Committees. The long term goals of the center will be to understand the biology of prostate cancer, to increase the number of African-American scientists in cancer research, and to educate the African-American community in the areas of prostate cancer prevention, early detection and treatment.

Public Health Relevance

Prostate cancer affects the African-American community disproportionately. There is an increased incidence/mortality rate for African-American men, however the reason for this is unknown. The Center for Cancer Research and Therapeutic Development is committed to focus on the impact of this health disparity within the African-American community

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Exploratory Grants (P20)
Project #
5P20MD002285-08
Application #
8708538
Study Section
Special Emphasis Panel (ZMD1-RN (04))
Program Officer
Mcclure, Shelia A
Project Start
2007-10-01
Project End
2017-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
8
Fiscal Year
2014
Total Cost
$246,174
Indirect Cost
$350,659
Name
Clark Atlanta University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
065325177
City
Atlanta
State
GA
Country
United States
Zip Code
30314
Muniyan, Sakthivel; Chou, Yu-Wei; Tsai, Te-Jung et al. (2015) p66Shc longevity protein regulates the proliferation of human ovarian cancer cells. Mol Carcinog 54:618-31
Brown, Shanora G; Knowell, Ashley E; Hunt, Aisha et al. (2015) Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis. Prostate 75:266-79
Smith, Basil; Randle, Diandra; Mezencev, Roman et al. (2014) Camalexin-induced apoptosis in prostate cancer cells involves alterations of expression and activity of lysosomal protease cathepsin D. Molecules 19:3988-4005
Burton, Liza J; Barnett, Petrina; Smith, Basil et al. (2014) Muscadine grape skin extract reverts snail-mediated epithelial mesenchymal transition via superoxide species in human prostate cancer cells. BMC Complement Altern Med 14:97
Mandal, S; Abebe, F; Chaudhary, J (2014) -174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race. Genet Mol Res 13:139-51
Smith, Bethany N; Burton, Liza J; Henderson, Veronica et al. (2014) Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2. PLoS One 9:e104987
Gryder, Berkley E; Akbashev, Michelle J; Rood, Michael K et al. (2013) Selectively targeting prostate cancer with antiandrogen equipped histone deacetylase inhibitors. ACS Chem Biol 8:2550-60
Chetram, Mahandranauth A; Hinton, Cimona V (2013) ROS-mediated regulation of CXCR4 in cancer. Front Biol (Beijing) 8:
Strong, Nicole; Millena, Ana C; Walker, Lindsey et al. (2013) Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFýý effects on cell proliferation and migration in prostate cancer cells. Prostate 73:624-33
Chetram, Mahandranauth A; Bethea, Danaya A; Odero-Marah, Valerie A et al. (2013) ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells. Mol Cell Biochem 376:63-71

Showing the most recent 10 out of 21 publications